Advanced glycation end products (AGEs) and their involvement in liver disease.
about
Does accumulation of advanced glycation end products contribute to the aging phenotype?Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaRole of receptor for advanced glycation end products (RAGE) in liver diseasePentosan polysulfate: a novel therapy for the mucopolysaccharidosesHepatic consequences of vascular adhesion protein-1 expressionMetabolism of AGEs--bacterial AGEs are degraded by metallo-proteasesToxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALDAdvanced glycation end product (AGE) modified proteins in tears of diabetic patientsInsulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men.Effect of dietary advanced glycation end products on mouse liverInvolvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesZingiber officinale acts as a nutraceutical agent against liver fibrosis.Oxidative stress in aging human skin.Small interfering RNA targeting receptor for advanced glycation end products suppresses the generation of proinflammatory cytokines.Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular CarcinomaAdvanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type MiceMetformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.Soluble receptor for advanced glycation end products and risk of liver cancer.Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children.Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.Losartan protects liver against ischaemia/reperfusion injury through PPAR-γ activation and receptor for advanced glycation end-products down-regulation.Coumarin derivatives: an updated patent review (2012-2014).In vivo imaging of advanced glycation end products (AGEs) of albumin: first observations of significantly reduced clearance and liver deposition properties in mice.Carbonyl stress phenomena during chronic infection with Opisthorchis felineus.Global Autorecognition and Activation of Complement by Mannan-Binding Lectin in a Mouse Model of Type 1 Diabetes.The receptor for advanced glycation end-products (RAGE) is only present in mammals, and belongs to a family of cell adhesion molecules (CAMs).Age dependent accumulation patterns of advanced glycation end product receptor (RAGE) ligands and binding intensities between RAGE and its ligands differ in the liver, kidney, and skeletal muscle.AGEs secreted by bacteria are involved in the inflammatory responseThe ubiquitous conserved glycopeptidase Gcp prevents accumulation of toxic glycated proteins.Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice.Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model.Formula derived Maillard reaction products in post-weaning intrauterine growth-restricted piglets induce developmental programming of hepatic oxidative stress independently of microRNA-21 and microRNA-155.Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.Asn-Trp dipeptides improve the oxidative stress and learning dysfunctions in D-galactose-induced BALB/c mice.Curcumin Exerts a Protective Effect against Premature Ovarian Failure in Mice.The Correlation Between Obesity-Related Diseases and Non-alcoholic Fatty Liver Disease in Women in the Pre-operative Evaluation for Bariatric Surgery Assessed by Transient Hepatic Elastography.Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma.Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
P2860
Q24632710-CA587652-0226-4856-9136-8535C52B8FC1Q26781477-9364BAB5-E0F2-4E2C-A060-38AB5B3AAF09Q27010462-4F32EA44-A01A-4062-9311-1F861E7FBED3Q27319509-6D9A3A30-76E8-45FC-896A-1B0C69FF64C9Q28236182-3489233B-968E-4C01-9D8D-B87C0ED29790Q28534296-05D083F4-D929-4C78-B4C4-C073717527A6Q33852213-E6916EB8-457A-4415-8910-8B71514C324AQ34081442-EA8E8700-0E37-4810-9173-E3DC1CAF95FDQ34185801-3C5E472E-D204-4954-BE1C-3AD4372C159BQ34230496-15D52D57-AE02-40D6-B821-9852A7679991Q34728267-3CC4801F-182F-4B49-AC2B-0444E98EDF90Q35426604-553C9687-6525-4714-83FE-F1F599970D66Q35833994-2F4BEA78-F033-4829-8122-A70F0222292FQ35870539-60B1C8EF-052C-4CEA-84A3-7CB87467DA2DQ36153175-B25E1B1A-283D-42EC-9256-1CAA25FBC059Q36578536-63A94E31-2B66-4BD7-BAF8-BDD05189D92FQ36788544-5CC2EE5E-9DD6-4A36-91BF-5F3E4190427EQ36816945-DC76BFEB-B3E0-4315-ABA3-2F7BDD2DEA69Q36963380-48A3E947-54F2-4404-9EBE-EDD2262A64FBQ37267277-385B1961-4964-4260-9B78-0497E93E3213Q37318895-48C373F0-ABE8-4E01-841B-E1F3682D0018Q38261279-BDB7FF7A-90E3-4A2E-A895-C46249ED7883Q38901241-4E8E2352-B905-4772-8E48-B65FBD6CAFBEQ39425969-7D0C6674-BA15-4A9D-963C-545E161347B7Q41038156-84CE97B5-E271-4222-9DD9-0E6FB3FC95B0Q41862027-8DFC97C3-49CA-43ED-B22E-7E8EF58AAE48Q41993914-70785793-86C2-4F57-9401-11951652ADB6Q42073893-3862111A-C395-4DD7-85B1-8C3083E2CCF5Q42115548-5384F931-9FFD-4348-BEBC-6D76513A263BQ43506762-2F5F8032-75E1-4F09-8166-A9CD19B19747Q46170526-D26B6EAA-3435-4903-B429-A875729A630DQ47223711-C54D92B9-1E52-421C-A386-A6F28CF44992Q47557029-39557850-CBFC-42C1-A394-CF2E00E9D1BCQ48641183-712481EC-4374-4196-8685-850CC3D264D2Q50043551-C5B0C028-B579-4736-854D-ED8DCD82DBD2Q50938841-BDD1B437-0107-4AD0-9FB2-8EA25DE6B571Q51315358-102D4E52-FE98-473B-A504-D26D9844FEC8Q55496728-40078051-3DD3-4984-9D42-E54E797DC90E
P2860
Advanced glycation end products (AGEs) and their involvement in liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advanced glycation end products (AGEs) and their involvement in liver disease.
@en
type
label
Advanced glycation end products (AGEs) and their involvement in liver disease.
@en
prefLabel
Advanced glycation end products (AGEs) and their involvement in liver disease.
@en
P1476
Advanced glycation end products (AGEs) and their involvement in liver disease.
@en
P2093
Hideyuki Hyogo
Sho-ichi Yamagishi
P304
P356
10.2174/138161208784139701
P577
2008-01-01T00:00:00Z